青光眼视神经中溶血磷脂及其转化酶的改变
研究比较人对照与青光眼视神经样本的溶血磷脂(LPL)谱及LPL通路转化酶,发现两组LPL谱主成分分析可区分,青光眼视神经中多种LPL降低而二酰甘油显著升高,部分转化酶mRNA表达显著改变,蛋白水平差异经Western blot和ELISA确认。
要点
- 青光眼视神经LPL谱与对照明显分离。
- 青光眼视神经中溶血磷脂酸、溶血磷脂酰乙醇胺、溶血磷脂酰胆碱降低,二酰甘油显著升高。
- 青光眼视神经中LPIN2、PLPP3、LCAT、CPLA2 mRNA显著上调,GPAT4显著下调。
核心结论
- 青光眼视神经存在特定LPL水平及相应转化酶改变。
研究设计与样本
- 对照(n=11)与青光眼(n=12)人视神经样本,脂质提取后行高分辨质谱分析LPL谱。
- 利用KEGG等工具构建LPL合成与降解通路,GEO数据集GSE45570分析mRNA表达。
- Western blot、ELISA和蛋白定量验证蛋白差异。
主要发现
- 主成分分析将对照与青光眼视神经LPL谱分为两组。
- 青光眼视神经中溶血磷脂酸、溶血磷脂酰乙醇胺、溶血磷脂酰胆碱降低,二酰甘油显著升高。
- 青光眼视神经中LPIN2、PLPP3、LCAT、CPLA2 mRNA显著过表达,GPAT4显著下调。
- Western blot和ELISA确认正常与病变视神经间蛋白差异。
临床怎么用
- 提示LPL代谢通路可能参与青光眼视神经病变,可作为潜在研究方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine whether lysophospholipid (LPL) profiles and corresponding conversion enzymes in the LPL pathways are altered in the optic nerve (ON) between human control and glaucoma samples. METHODS: Lipids extracted from control (n = 11) and glaucomatous (n = 12) ON samples using the Bligh and Dyer method were subjected to high-resolution mass spectrometry on a Q-exactive mass spectrometer coupled with a high-performance liquid chromatography (Accela 600) system. Analysis was performed for LPLs (lysophosphatidylcholines, lysophosphatidylserines, lysophosphatidylethanolamines, lysophosphatidylinositols, and lysosphingomyelines) using LipidSearch v.4.1, MZmine v.2.0, and MetaboAnalyst v.4.0. LPL synthesis and degradation pathway maps, utilizing UniProt and BRENDA database entries as needed, were created using Kyoto Encyclopedia of Genes and Genomes (KEGG)-based tools. The mRNA expression level in normal and glaucomatous human ON were analyzed using Gene Expression Omnibus (GEO) entry GSE45570. Protein amounts were determined using PHAST gel and dot blot and were used for normalization of protein amounts across samples. Western blot, ELISA, and protein quantification were performed using established protocols. RESULTS: Principal component analysis of ON LPL profile placed control and glaucomatous ONs in two distinct separate groups. Mass spectrometric analysis of ON revealed decrease in lysophosphatidic acid, lysophosphatidylethanolamine, lysophosphatidylcholine, and significant increase in diacylglycerol in glaucomatous ON. Statistical analysis of LPL conversion enzymes revealed significant overexpression of phosphatidate phosphatase LPIN2, phospholipid phosphatase 3, phosphatidylcholine-sterol acyltransferase, and calcium-dependent phospholipase 2, and significant downregulation of glycerol-3-phosphate acyltransferase 4 at mRNA level in glaucomatous ON. Western blot and ELISA confirmed proteomic differences between normal and diseased ON. CONCLUSIONS: Our analysis revealed alterations in specific LPL levels and corresponding select enzyme-level changes in glaucomatous ON.
引用
- Milbeck SM, Bhattacharya SK. Alteration in Lysophospholipids and Converting Enzymes in Glaucomatous Optic Nerves. Invest Ophthalmol Vis Sci. 2020. PMID: 32602905. doi:10.1167/iovs.61.6.60
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。